2014 Insurance Coverage and Processing Labelling 
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. weight reduction in obese individuals, as per its label. In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics.
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. weight reduction in obese individuals, as per its label. In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics.
Expert insights. Personalized for you.
105 
Let's personalize your content